Approval · Notice of Compliance 16722 · 2015
FUROSEMIDE: Notice of Compliance 16722
Issued March 24, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16722
- Date
- March 24, 2015
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- Diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FUROSEMIDE | 02351420 | Cancelled Post Market |
| FUROSEMIDE | 02351439 | Cancelled Post Market |
| FUROSEMIDE | 02351447 | Cancelled Post Market |
Medicinal ingredients
- FUROSEMIDE 20 MG per TAB
- FUROSEMIDE 40 MG per TAB
- FUROSEMIDE 80 MG per TAB